Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas
- 1 June 2013
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 129 (3), 478-485
- https://doi.org/10.1016/j.ygyno.2013.03.011
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Molecular Profile of Grade 3 Endometrioid Endometrial CarcinomaThe American Journal of Surgical Pathology, 2012
- Comparison of Survival Outcomes Between Patients With Malignant Mixed Mullerian Tumors and High-Grade Endometrioid, Clear Cell, and Papillary Serous Endometrial CancersInternational Journal of Gynecologic Cancer, 2011
- Gene Expression Profiles in Stage I Uterine Serous Carcinoma in Comparison to Grade 3 and Grade 1 Stage I Endometrioid AdenocarcinomaPLOS ONE, 2011
- Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studiesEuropean Journal Of Cancer, 2010
- Does Surgical Quality Improve in the American College of Surgeons National Surgical Quality Improvement ProgramAnnals of Surgery, 2009
- Role of cytoreduction in stage III and IV uterine papillary serous carcinomaGynecologic Oncology, 2007
- Uterine serous and grade 3 endometrioid carcinomasCancer, 2004
- FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survivalInternational Journal of Gynecologic Cancer, 2002
- Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome of Locoregional (Stage I–III) DiseaseGynecologic Oncology, 2001
- The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid CarcinomaGynecologic Oncology, 2000